Do Analysts Think Eyenovia Inc (EYEN) Is Still Worth Buying In 2024?

Eyenovia Inc (NASDAQ:EYEN) does about 1.64M shares in volume on a normal day but saw 1837216 shares change hands in the recent trading day. The company now has a market cap of 47.05M USD. Its current market price is $0.55, marking an increase of 2.00% compared to the previous close of $0.54. The 52 week high reached by this stock is $2.57 whilst the lowest price level in 52 weeks is $0.37.

Eyenovia Inc (EYEN) has a 20-day trading average at $0.4989 and the current price is -78.60% off the 52-week high compared with 48.65% distance from its 52-week low. The 50-day simple moving average of the closing price is $0.5206 and its 200-day simple moving average is $0.9779. If we look at the stock’s price movements over the week, volatility stands at 7.60%, which increases to 9.11% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 54.61 to suggest the stock is neutral.

The consensus objective for the share price is $7.67, suggesting that the stock has a potential upside of 92.83% over the period.

The company shares received a number of brokerage firm price updates over the past month, with the latest being on March 01, 2021 when Northland Capital initiated the stock to “Outperform” and issued a price target of $10.

The current price level is 10.30%, 5.67%, and -43.76% away from its SMA20, SMA50, and SMA200 respectively, with the EYEN price moving below the 50-day SMA on current market day. Eyenovia Inc (EYEN) stock is down -0.90% over the week and 11.09% over the past month. Its price is -73.56% year-to-date and -50.89% over the past year.

The company’s next earnings report forecasts estimating quarterly EPS at -0.13 and -0.65 for whole year. Expected sales for next quarter are $1.7M, which analysts say will come at $1.89M for the current fiscal year and next year at $9.43M. In addition, estimates put the company’s current quarterly revenue at an average of $160k.

To reach the target analysts have set, the stock logically needs to grow 92.83 percent from here.

The company has a return on investment of -1184.92% and return on equity of -914.66%. The beta has a value of 1.75. Price to sales ratio is 1568.23.